AI-Assisted Treatment for Residual Speech Sound Disorders
ConditionSpeech Sound Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-17
SponsorSyracuse University
About this trial
The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, for 5 weeks with a human speech-language clinician. Some participants will receive 3 speech sessions per week with an Artificial Intelligence (AI)-clinician during the same 5 weeks as the human clinician sessions (CONCURRENT treatment order group), whereas others will receive 3 speech sessions per week with an AI-clinician after the human clinician sessions end (SEQUENTIAL treatment order group.
Eligibility criteria
Qualifiers
Must speak a rhotic dialect of American English as a dominant language.
Must have begun learning English by at least the age of 3 years.
Must be between 9;0 to 17;11 years of age.
Must have reported difficulty with /ɹ/ production.
Disqualifiers
Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke.
Must not have diagnosis of attention deficit disorder, attention deficit hyperactivity disorder, Tourette's, or Obsessive-compulsive disorder.
Must have no orthodontic appliances that block the roof of the mouth (e.g., palate expanders).
Must not have current cleft palate, fluency disorder, or voice disorder.
Trial design
Treatments tested in this trial
- Speech-Language Pathologist-led Speech Motor Chaining
- Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI)
Treatment groups
26 Participants
are divided into 2 treatment groupsSponsors and collaborators
Syracuse University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
State University of New York - Upstate Medical University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
Source ClinicalTrials.gov